WPRIM Management System> DCMS> National Journal of Andrology> 2007> 13> 3

Volume: 13 Issue: 3

1. Advances in the studies on the safety of tadalafil in treating erectile dysfunction. Page:280—284
2. Vascular factors in the pathogenesis of diabetic erectile dysfunction. Page:255—259
3. Update of the researches on sperm proteome. Page:250—254
4. Progress in the studies of Gardnerella vaginal. Page:246—249
5. Transient receptor potential ion channels and prostatic diseases. Page:242—245
6. Effects of triptolide on prostate carcinoma in mouse RM-1 cells. Page:237—241
7. Clinical efficacy and safety of recombinant human-growth hormone in the treatment of idiopathic asthenospermia. Page:233—236
8. Construction and identification of bait recombinant vector of pGBKT7-tumor necrosis factor-alpha converting enzyme cytoplasmic tail in the yeast two-hybrid system. Page:229—232
9. Experience of using three phosphodiesterase type 5 inhibitors in the same period for the treatment of erectile dysfunction. Page:226—228
10. Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer. Page:222—225
11. Endoscopic treatment of urethra stenosis by super-impulse plasma electrode. Page:219—221
12. Laser-assisted immobilization causes no direct damage to sperm DNA. Page:216—218
13. Ultrasonographic changes in the epididymis after long-term vasectomy. Page:212—215
14. Primitive research on the effect of FSH autoantibody on the spermatogenic capability of the rat testis. Page:206—211
15. Suppression of invasion and angiogenesis in human prostate cancer PC-3 cells by adenovirus-mediated co-transfer of PTEN and P27. Page:201—205
16. Relationship between phthalates and testicular dysgenesis syndrome. Page:195—200